Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

PHASE4RecruitingINTERVENTIONAL
Enrollment

294

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Antiplatelet TherapyHemorrhagic Infarction
Interventions
DRUG

Early aspirin Therapy

Early Antiplatelet Therapy is administered within 24 to 48 hours after stroke onset and the dose is determined by the clinician. Aspirin was chosen for antiplatelet therapy.

DRUG

Non-Early aspirin Therapy

Antiplatelet therapy will be delayed to beyond 48 hours after stroke onset and may not be initiated until hemorrhagic Infarction has been confirmed absorbed.

Trial Locations (1)

Unknown

RECRUITING

the second affiliated hospital of Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Shaoxing People's Hospital

OTHER

collaborator

Affiliated Hospital of Jiaxing University

OTHER

collaborator

Huzhou Central Hospital

OTHER

collaborator

The Second Affiliated Hospital of Jiaxing University

OTHER

collaborator

Jinhua Central Hospital

OTHER

collaborator

Taizhou Hospital

OTHER

collaborator

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

collaborator

Ningbo No.2 Hospital

OTHER

collaborator

Lishui Country People's Hospital

OTHER

collaborator

Wenzhou Central Hospital

OTHER

collaborator

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER

collaborator

Shenzhen Second People's Hospital

OTHER

collaborator

The Affiliated Hospital of Xuzhou Medical University

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER